Page 7 of 9, showing 50 records out of 429 total, starting on record 301, ending on 350
| Publication |
Category |
Year |
|
135. Labrie, F. (1993) Intracrinology: its impact on prostate cancer. Curr. Opin. Urol., 3: 381-387. |
Intracrinology |
1993 |
|
136. Labrie, F. (1993) Mechanism of action and pure antiandrogenic properties of Flutamide. Cancer, 72: 3816-3827. |
Intracrinology |
1993 |
|
137. Labrie, F. (1993) Non-steroidal antiandrogens, in: Droz, J.P., Cvitkovic, E., Armand, J.P. et Khoury, S., eds: Handook of Chemotherapy in Clinical Oncology, London, Scientific Communication International Ltd., pp 389-391. |
Intracrinology |
1993 |
|
139. Labrie, F., Bélanger, A., Dupont, A., Luu-The, V., Simard, J., Labrie, C. (1993) Science behind total androgen blockade: from gene to combination therapy. Clin. Invest. Med., 16: 475-492. |
Intracrinology |
1993 |
|
143. Labrie, F., Dupont, A., Simard, J., Luu-The, V., Bélanger, A. (1993) Intracrinology: the basis for the rational design of endocrine therapy at all stages of prostate cancer. Eur. Urol., 24 Suppl. 2: 94-105. |
Intracrinology |
1993 |
|
963. Labrie, F., Simard, J., Luu-The, V., Pelletier, G., Labrie, C., Dupont, E., Martel, C., Couet, J., Trudel, C., Rhéaume, E., Breton, N., de Launoit, Y., Dumont, M., Zhao, H.F., Lachance, Y. (1993) Structure and control of expression of the 3β-HSD and 17β-HSD genes in classical steroidogenic and peripheral intracrine tissues, in: Leung, P.C.K., Hsueh, A.J.W. et Friesen, H.G., eds: Molecular Basis of Reproductive Endocrinology, New York, Karger, pp 112-143. |
Intracrinology |
1993 |
|
470. Li, S., Yan, X., Bélanger, A., Labrie, F. (1993) Prevention by dehydroepiandrosterone of the development of mammary carcinoma induced by 7,12-dimethylbenz(?)anthracene (DMBA) in the rat. Breast Cancer Res. Treat., 29: 203-217. |
Intracrinology |
1993 |
|
145. Martel, C., Trudel, C., Couet, J., Labrie, C., Bélanger, A., Labrie, F. (1993) Blockade of androstenedione-induced stimulation of androgen-sensitive parameters in the rat prostate by combination of Flutamide and 4-MA. Mol. Cell. Endocrinol., 91: 43-49. |
Intracrinology |
1993 |
|
146. Normand, T., Narod, S., Labrie, F., Simard, J. (1993) Detection of polymorphisms in the estradiol 17β-hydroxysteroid dehydrogenase II gene at the human EDH17B2 locus on 17q11-q21. Hum. Mol. Genet., 2: 479-483. |
Intracrinology |
1993 |
|
967. Riley, S.C., Bassett, N.S., Berdusco, E.T., Yang, K., Leystra-Lantz, C., Luu-The, V., Labrie, F., Challis, J.R. (1993) Changes in the abundance of mRNA for type I 3β-hydroxysteroid dehydrogenase/Δ5-Δ4 isomerase in the human placenta and fetal membranes during pregnancy and labor. Gynecol. Obstet. Invest., 35: 199-203. |
Intracrinology |
1993 |
|
367. Simard, J., Couet, J., Durocher, F., Labrie, Y., Sanchez, R., Breton, N., Turgeon, C., Labrie, F. (1993) Structure and tissue-specific expression of a novel member of the rat 3β-hydroxysteroid dehydrogenase/Δ5-Δ4 isomerase (3β-HSD) family: the exclusive 3β-HSD gene expressed in the skin. J. Biol. Chem., 268: 19659-19668. |
Intracrinology |
1993 |
|
969. Simard, J., Rhéaume, E., Sanchez, R., de Launoit, Y., Laflamme, N., Luu-The, V., van Seters, A.P., Gordon, R.D., Heinrich, U., Moshang, T., New, M.I., Labrie, F. (1993) Molecular basis of congenital adrenal hyperplasia due to 3?-hydroxysteroid dehydrogenase deficiency. Mol. Endocrinol., 7: 716-728. |
Intracrinology |
1993 |
|
970. Couët, J., Simard, J., Martel, C., Trudel, C., Labrie, Y., Labrie, F. (1992) Regulation of 3-ketosteroid reductase mRNA levels and 3β-hydroxysteroid dehydrogenase/Δ5-Δ4 isomerase activity in rat liver by sex steroids and pituitary hormones. Endocrinology, 131: 3034-3044. |
Intracrinology |
1992 |
|
971. de Launoit, Y., Simard, J., Durocher, F., Labrie, F. (1992) Androgenic 17β-hydroxysteroid dehydrogenase activity of expressed rat type I 3β-hydroxysteroid dehydrogenase/Δ5-Δ4 isomerase. Endocrinology, 130: 553-555. |
Intracrinology |
1992 |
|
972. de Launoit, Y., Zhao, H.F., Bélanger, A., Labrie, F., Simard, J. (1992) Expression of liver specific member of the 3β-hydroxysteroid dehydrogenase family, an isoform possessing an almost exclusive 3-keto steroid reductase activity. J. Biol. Chem., 267: 4513-4517. |
Intracrinology |
1992 |
|
973. Dumont, M., Luu-The, V., de Launoit, Y., Labrie, F. (1992) Expression of human 17β-hydroxysteroid dehydrogenase in mammalian cells. J. Steroid Biochem. Mol. Biol., 41: 605-608. |
Intracrinology |
1992 |
|
368. Dumont, M., Luu-The, V., Dupont, E., Pelletier, G., Labrie, F. (1992) Characterization, expression and immunohistochemical localization of 3β-hydroxysteroid dehydrogenase/Δ5-Δ4 isomerase in human skin. J. Invest. Dermatol., 99: 415-421. |
Intracrinology |
1992 |
|
975. Dupont, E., Labrie, F., Luu-The, V., Pelletier, G. (1992) Immunocytochemical localization of 3β-hydroxysteroid dehydrogenase/Δ5-Δ4 isomerase (3β-HSD) in human ovary. J. Clin. Endocrinol. Metab., 74: 994-998. |
Intracrinology |
1992 |
|
473. Labrie, C., Martel, C., Dufour, J.M., Lévesque, C., Mérand, Y., Labrie, F. (1992) Novel compounds inhibit estrogen formation and action. Cancer Res., 52: 610-615. |
Intracrinology |
1992 |
|
474. Labrie, F., Simard, J., de Launoit, Y., Poulin, R., Thériault, C., Dumont, M., Dauvois, S., Martel, C., Li, S.; (1992) Androgens and breast cancer. Cancer Detect. Prev., 16: 31-38. |
Intracrinology |
1992 |
|
978. Labrie, F., Simard, J., Luu-The, V., Bélanger, A., Pelletier, G. (1992) Structure, function and tissue-specific gene expression of 3β-hydroxysteroid dehydrogenase/5-ene-4-ene isomerase enzymes in classical and peripheral intracrine steroidogenic tissues. J. Steroid Biochem. Mol. Biol., 43: 805-826. |
Intracrinology |
1992 |
|
979. Labrie, F., Simard, J., Luu-The, V., Pelletier, G., Bélanger, A. (1992) Cloning, expression and regulation of tissue-specific expression of 3β-hydroxysteroid dehydrogenase/Δ5-Δ4 isomerase in Cellular and Molecular Biology of the Adrenal Cortex, London, John Libbey Eurotext Ltd., pp 89-109. |
Intracrinology |
1992 |
|
980. Labrie, F., Simard, J., Luu-The, V., Pelletier, G., Bélanger, A., Lachance, Y., Zhao, H.F., Labrie, C., Breton, N., de Launoit, Y., Dumont, M., Dupont, E., Rhéaume, E., Martel, C., Couët, J., Trudel, C. (1992) Structure and tissue-specific expression of 3β-hydroxysteroid dehydrogenase/5-ene-4-ene isomerase genes in human and rat classical and peripheral steroidogenic tissues. J. Steroid Biochem. Mol. Biol., 41: 421-435. |
Intracrinology |
1992 |
|
981. Labrie, F., Sugimoto, Y., Luu-The, V., Simard, J., Lachance, Y., Bachvarov, D., Leblanc, G., Durocher, F., Paquet, N. (1992) Structure of human type II 5α-reductase gene. Endocrinology, 131: 1571-1573. |
Intracrinology |
1992 |
|
982. Lin, S.-X., Yang, F., Jin, J.-Z., Breton, R., Zhu, D.-W., Luu-The, V., Labrie, F. (1992) Subunit identity of the dimeric 17β-hydroxysteroid dehydrogenase from human placenta. J. Biol. Chem., 267: 16182-16187. |
Intracrinology |
1992 |
|
983. Martel, C., Rhéaume, E., Takahashi, M., Trudel, C., Couët, J., Luu-The, V., Simard, J., Labrie, F. (1992) Distribution of 17β-hydroxysteroid dehydrogenase gene expression and activity in rat and human tissues. J. Steroid Biochem. Mol. Biol., 41: 597-603. |
Intracrinology |
1992 |
|
153. Martel, C., Trudel, C., Couet, J., Labrie, C., Bélanger, A., Labrie, F. (1992) Blockade of androgen action by combined treatment with a pure antiandrogen (Flutamide) and a 5α-reductase inhibitor (4-MA), in: Giuliani, L. et Puppo, P., eds: Urology, Bologna, Monduzzi Editore, pp 605-610. |
Intracrinology |
1992 |
|
985. Pelletier, G., Dupont, E., Simard, J., Luu-The, V., Bélanger, A., Labrie, F. (1992) Ontogeny and subcellular localization of 3β-hydroxysteroid dehydrogenase (3β-HSD) in the human and rat adrenal, ovary and testis. J. Steroid Biochem. Mol. Biol., 43: 451-467. |
Intracrinology |
1992 |
|
987. Rösler, A., Bélanger, A., Labrie, F. (1992) Mechanisms of androgen production in male pseudohermaphroditism due to 17β-hydroxysteroid dehydrogenase deficiency. J. Clin. Endocrinol. Metab., 75: 773-778. |
Intracrinology |
1992 |
|
986. Rhéaume, É., Simard, J., Morel, Y., Mebarki, F., Zachmann, M., Forest, M.G., New, M.I., Labrie, F. (1992) Congenital adrenal hyperplasia due to point mutations in the type II 3β-hydroxysteroid dehydrogenase gene. Nat. Genet., 1: 239-245. |
Intracrinology |
1992 |
|
476. Roy, R., Dauvois, S., Labrie, F., Bélanger, A. (1992) Estrogen-stimulated glucuronidation of dihydrotestosterone in MCF-7 human breast cancer cells. J. Steroid Biochem. Mol. Biol., 41: 579-582. |
Intracrinology |
1992 |
|
477. Simard, J., de Launoit, Y., Haagensen, D.E., Labrie, F. (1992) Additive stimulatory action of glucocorticoids and androgens on basal and estrogen-repressed apolipoprotein D messenger RNA levels and secretion in human breast cancer cells. Endocrinology, 130: 1115-1121. |
Intracrinology |
1992 |
|
478. Dauvois, S., Geng, C.S., Lévesque, C., Mérand, Y., Labrie, F. (1991) Additive inhibitory effects of an androgen and the antiestrogen EM-170 on estradiol-stimulated growth of human ZR-75-1 breast tumors in athymic mice. Cancer Res., 51: 3131-3135. |
Intracrinology |
1991 |
|
479. de Launoit, Y., Dauvois, S., Dufour, M., Simard, J., Labrie, F. (1991) Inhibition of cell cycle kinetics and proliferation by the androgen 5α-dihydrotestosterone and antiestrogen N,n-butyl-N-methyl-11-[16'a-chloro-3',17β-dihydroxy-estra-1',3',5'-(10')triene-7'a-yl] undecanamide in human breast cancer ZR-75-1 cells. Cancer Res., 51: 2797-2802. |
Intracrinology |
1991 |
|
156. de Launoit, Y., Veilleux, R., Dufour, M., Simard, J., Labrie, F. (1991) Characteristics of the biphasic action of androgens and of the potent antiproliferative effects of the new pure antiestrogen EM-139 on cell cycle kinetic parameters in LNCaP human prostatic cancer cells. Cancer Res., 51: 5165-5170. |
Intracrinology |
1991 |
|
993. Dupont, A., Dupont, P., Cusan, L., Tremblay, M., Gomez, J.L., Mailloux, J., de Lignières, B., Bélanger, A., Labrie, F. (1991) Efficacy of percutaneous estradiol and oral estrogens as replacement therapy in postmenopausal women, in : Dusitsin, N. et Notelovitz, M., eds: Physiological Hormone Replacement Therapy, New Jersey, USA, The Parthenon Publishing Group, pp 37-50. |
Intracrinology |
1991 |
|
994. Dupont, A., Dupont, P., Cusan, L., Tremblay, M., Rioux, J., Cloutier, D., Mailloux, J., De Lignières, B., Gutkowska, J., Boucher, H., Bélanger, A., Moyer, D.L., Moorjani, S., Labrie, F. (1991) Comparative endocrinological and clinical effects of percutaneous estradiol and oral conjugated estrogens as replacement therapy in menopausal women. Maturitas, 13: 297-311. |
Intracrinology |
1991 |
|
995. Dupont, E., Labrie, F., Luu-The, V., Pelletier, G. (1991) Localization of 17beta-hydroxysteroid dehydrogenase throughout gestation in the human placenta. J. Histochem. Cytochem., 39: 1403-1407. |
Intracrinology |
1991 |
|
996. Dupont, E., Luu-The, V., Labrie, F., Pelletier, G. (1991) Ontogeny of 3beta-hydroxysteroid dehydrogenase/ Delta5-Delta4 isomerase (3beta-HSD) in human testis as studied by immunocytochemistry. J. Androl., 12: 161-164. |
Intracrinology |
1991 |
|
997. Dupont, E., Rhéaume, E., Simard, J., Luu-The, V., Labrie, F., Pelletier, G. (1991) Ontogenesis of 3beta-hydroxysteroid dehydrogenase/Delta5-Delta4 isomerase in the rat adrenal as revealed by immunocytochemistry and in situ hybridization. Endocrinology, 129: 2687-2692. |
Intracrinology |
1991 |
|
481. Lévesque, C., Mérand, Y., Dufour, J.M., Labrie, C., Labrie, F. (1991) Synthesis and biological activity of new halo-steroidal antiestrogens. J. Med. Chem., 34: 1624-1630. |
Intracrinology |
1991 |
|
998. Labrie, C., Martel, C., Couet, J., Trudel, C., Luu-The, V., Labrie, F. (1991) Pituitary hormone regulation of ovarian 3beta-HSD gene expression and activity in the rat (Chapter 27), in: Gibori, G., ed. Signaling Mechanisms and Gene Expression in the Ovary (Serono Symposia), New York, Springer-Verlag, pp 268-273. |
Intracrinology |
1991 |
|
158. Labrie, C., Trudel, C., Li, S., Martel, C., Couët, J., Labrie, F. (1991) Combination of an antiandrogen and a 5a-reductase inhibitor: a further step towards total androgen blockade? Endocrinology, 129: 566-568. |
Intracrinology |
1991 |
|
160. Labrie, F. (1991) Intracrinology. Mol. Cell. Endocrinol., 78: C113-C118. |
Intracrinology |
1991 |
|
161. Labrie, F., Dupont, A., Cusan, L., Manhès, G., Lacourcière, Y., Monfette, G., Emond, J. (1991) Maximal androgen blockade in prostate cancer: To-Day's Therapy of choice and 5-year clinical experience, in: Vickery, B.H. et Lunenfeld, B., eds: International Symposium on GnRH analogues in Cancer and Human Reproduction, The Netherlands, Kluwer Academic Publishers, pp 79-102. |
Intracrinology |
1991 |
|
3990. Labrie, F., Simard, J., Luu-The, V., Bélanger, A., Cusan, L., Dupont, A., Trudel, C., Martel, C., Labrie, C., Zhao, H.F., Dupont, E., Couet, J., Lachance, Y., Dumont, M., de Launoit, Y., Breton, N. (1991) Androgens in post-menopause, in: Rivista di Ostetricia e Ginecologia Pratica e Medicina Perinatale, Palermo, pp 15-24. |
Intracrinology |
1991 |
|
1003. Labrie, F., Simard, J., Luu-The, V., Trudel, C., Martel, C., Labrie, C., Zhao, H.F., Rhéaume, E., Couet, J., Breton, N. (1991) Expression of 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase (3beta-HSD) and 17beta-hydroxysteroid dehydrogenase (17beta-HSD) in adipose tissue. Int. J. Obstet., 15 Suppl. 2: 91-99. |
Intracrinology |
1991 |
|
1004. Lachance, Y., Luu-The, V., Verreault, H., Dumont, M., Rhéaume, E., Leblanc, G., Labrie, F. (1991) Structure of human 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase (3beta-HSD) gene-adrenal and gonadal specificity. DNA Cell Biol., 10: 701-711. |
Intracrinology |
1991 |
|
1006. Luu-The, V., Takahashi, M., de Launoit, Y., Dumont, M., Lachance, Y., Labrie, F. (1991) Evidence for distinct dehydrogenase and isomerase sites within a single 3beta-hydroxysteroid dehydrogenase 5-ene-4-ene-isomerase protein. Biochemistry, 30: 8861-8865. |
Intracrinology |
1991 |
|
1007. Luu-The, V., Takahashi, M., Labrie, F. (1991) Differential inhibition of dehydrogenase and 5-ene-4-ene isomerase activities of purified 3beta-hydroxysteroid dehydrogenase. Evidence for two distinct sites. J. Steroid Biochem. Molec. Biol., 40: 545-548. |
Intracrinology |
1991 |